EP 1556074 A4 20080507 - CASEIN DERIVED PEPTIDES AND USES THEREOF IN THERAPY
Title (en)
CASEIN DERIVED PEPTIDES AND USES THEREOF IN THERAPY
Title (de)
VON CASEIN ABGELEITETE PEPTIDE UND DEREN VERWENDUNG IN DER THERAPIE
Title (fr)
PEPTIDES DERIVES DE LA CASEINE ET LEURS UTILISATIONS THERAPEUTIQUES
Publication
Application
Priority
- IL 0200720 W 20020829
- US 94212101 A 20010830
Abstract (en)
[origin: WO03018606A2] Biologically active peptides that are derived from or are similar to sequences identical with the N-terminus of the S1 fraction of milk casein. These peptides are capable of stimulating and enhancing immune response, protecting against viral infection, normalizing serum cholesterol levels, and stimulating hematopoiesis. The casein-derived peptides are non-toxic and can be used to treat and prevent immune pathologies, hypercholesterolemia, hematological disorders and viral-related diseases.
IPC 1-7
A61K 38/17; A61K 38/00; A01N 37/18; C07K 5/00; C07K 7/00; C07K 16/00; C07K 17/00
IPC 8 full level
A61K 38/17 (2006.01); A61P 3/06 (2006.01); A61P 3/10 (2006.01); A61P 7/00 (2006.01); A61P 7/04 (2006.01); A61P 7/06 (2006.01); A61P 31/12 (2006.01); A61K 38/00 (2006.01); A61P 31/18 (2006.01); A61P 35/02 (2006.01); A61P 37/02 (2006.01); A61P 39/00 (2006.01); A61P 43/00 (2006.01); C07K 5/06 (2006.01); C07K 5/08 (2006.01); C07K 5/10 (2006.01); C07K 7/00 (2006.01); C07K 14/47 (2006.01)
CPC (source: EP KR)
A61K 38/16 (2013.01 - KR); A61K 38/1709 (2013.01 - EP); A61P 3/06 (2018.01 - EP); A61P 3/10 (2018.01 - EP); A61P 7/00 (2018.01 - EP); A61P 7/04 (2018.01 - EP); A61P 7/06 (2018.01 - EP); A61P 31/12 (2018.01 - EP); A61P 31/18 (2018.01 - EP); A61P 35/02 (2018.01 - EP); A61P 37/00 (2018.01 - EP); A61P 37/02 (2018.01 - EP); A61P 37/04 (2018.01 - EP); A61P 39/00 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07K 14/4732 (2013.01 - EP)
Citation (search report)
- [XP] WO 0164234 A1 20010907 - CHAY 13 MEDICAL RES GROUP N V [NL], et al
- [X] FR 2118134 A1 19720728 - ASSAD NAJJAR V [US]
- [X] KARIYA K ET AL: "INHIBITION OF ANGIOTENSIN CONVERTING ENZYME OF RAT BRAIN WITH BRADYKININ AND ITS FRAGMENTS", BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, ACADEMIC PRESS, SAN DIEGO, CA, US, vol. 100, no. 1, 1981, pages 31 - 36, XP008066034, ISSN: 0006-291X
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
Designated extension state (EPC)
AL LT LV MK RO SI
DOCDB simple family (publication)
WO 03018606 A2 20030306; WO 03018606 A3 20050506; WO 03018606 A9 20040408; AU 2002324323 A2 20030310; BR 0212625 A 20070619; CA 2458924 A1 20030306; CN 1694719 A 20051109; CZ 2004335 A3 20040714; EP 1556074 A2 20050727; EP 1556074 A4 20080507; HU P0500995 A2 20070502; HU P0500995 A3 20080929; IL 160548 A0 20040725; JP 2005511499 A 20050428; KR 20040078639 A 20040910; MX PA04001890 A 20040618; NO 20040880 L 20040420; PL 375113 A1 20051128; ZA 200401574 B 20070228
DOCDB simple family (application)
IL 0200720 W 20020829; AU 2002324323 A 20020829; BR 0212625 A 20020829; CA 2458924 A 20020829; CN 02821674 A 20020829; CZ 2004335 A 20020829; EP 02758768 A 20020829; HU P0500995 A 20020829; IL 16054802 A 20020829; JP 2003523265 A 20020829; KR 20047002884 A 20020829; MX PA04001890 A 20020829; NO 20040880 A 20040227; PL 37511302 A 20020829; ZA 200401574 A 20040226